Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor.
Pretreatment with a low dose of recombinant human interleukin-1 beta (IL-1) (3 to 30 micrograms/kg) 24 h before a lethal Pseudomonas aeruginosa infection prolongs survival in neutropenic mice. We investigated the role of the type I IL-1 receptor (IL-1RI) and IL-1RII in this IL-1-induced protection b...
I tiakina i:
| I whakaputaina i: | Antimicrob Agents Chemother |
|---|---|
| Ngā kaituhi matua: | , , , |
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
American Society for Microbiology (ASM)
1995
|
| Ngā marau: | |
| Urunga tuihono: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC162819/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7486912/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.39.8.1744 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|